You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial

 

Online download statistics by month:

Online download statistics by month: May 2020 to March 2024

AbstractFullPdf
May 2020421421223
Jun 202026326392
Jul 2020217217112
Aug 202016816858
Sep 2020277277113
Oct 202020820892
Nov 2020173172121
Dec 202013413464
Jan 202117417489
Feb 202119519562
Mar 202121821884
Apr 202125525568
May 2021269269114
Jun 202125525588
Jul 202121921978
Aug 202121221278
Sep 202121421465
Oct 2021233233101
Nov 202124724895
Dec 202119520086
Jan 202220421780
Feb 202220922972
Mar 202219419983
Apr 202224826590
May 202221822679
Jun 202221121755
Jul 202218018247
Aug 202221521777
Sep 202220320672
Oct 202222022279
Nov 202231531998
Dec 202218318447
Jan 202322722949
Feb 202321221474
Mar 202325125151
Apr 202314114240
May 202315315449
Jun 202311711733
Jul 202314014130
Aug 202316616552
Sep 202315816138
Oct 202315315340
Nov 202313814156
Dec 202313213335
Jan 2024878831
Feb 202411811832
Mar 202415916088
Total949996023460